Cubist Pharma CEO: Open to Acquisitions & Being Acquired

Monday, 16 Dec 2013 | 10:00 AM ET

Cubist Pharmaceutical CEO Michael Bonney talks to CNBC's Bertha Coombs about his company's big bet on antibiotics to treat superbugs, which recently drove the firm to acquire two smaller rivals. He leaves the door open to future deals.